Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle

Applied Microbiology and Biotechnology

Volumn 99, Issue 3, 2015, Pages 1389-1398

  Zhang, Zhongwang ^a,b   Pan, Li ^a,b   Ding, Yaozhong ^a,b   Zhou, Peng ^a,b   Lv, Jianliang ^a,b   Chen, Haotai ^a,b   Fang, Yuzhen ^a,b   Liu, Xinsheng ^a,b   Chang, Huiyun ^a,b   Zhang, Jie ^a,b   Shao, Junjun ^a,b   Lin, Tong ^a,b   Zhao, Furong ^a,b   Zhang, Yongguang ^a,b   Wang, Yonglu ^a,b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

Cattle; Foot and mouth disease virus; Serotype A; Synthetic peptide vaccines

Indexed keywords

AGRICULTURE; DEVELOPING COUNTRIES; MAMMALS; PEPTIDES; VACCINES; VIRUSES;

CATTLE; FOOT AND MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOPROTECTION; NEUTRALIZING ANTIBODIES; PEPTIDE VACCINES; SEROTYPES; SYNTHETIC PEPTIDE;

DISEASES;

FOOT AND MOUTH DISEASE VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; PEPTIDE PA; PEPTIDE PB; PEPTIDE PC; PEPTIDE VACCINE; PROTEIN VP1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; CAPSID PROTEIN; RECOMBINANT VACCINE; SUBUNIT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CATTLE DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL GUINEA PIG; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS A; IMMUNITY; IMMUNOGENICITY; MALE; NONHUMAN; SEROTYPE; VACCINATION; VIRUS STRAIN; ANIMAL; BOVINE; CATTLE DISEASES; FOOT-AND-MOUTH DISEASE; GENETICS; GUINEA PIG; IMMUNOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CATTLE; CATTLE DISEASES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84925521525     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-6129-1     Document Type: Article

References (56)

1. Antoni F, Soos T, Varga J, Mecs I, Penke B, Horvath K, Bognar K, Tuboly S (1988) Efficacy of experimental synthetic peptide vaccines against foot and mouth disease. Magyar Allatovosok Lapja 43:561–566
2. Barnett PV, Carabin H (2002) A review of emergency foot-and-mouth disease (FMD) vaccine. Vaccine 20:1505–1514
3. Barnett PV, Statham RJ (2002) Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage. Vaccine 20:2060–2064
4. Barteling SJ, Vreeswijk J (1991) Developments in foot-and-mouth disease vaccines. Vaccine 9:75–88
5. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
6. Blanco E, Garcia-Briones M, Sanz-Parra A, Gomes P, De Oliveira E, Valero ML, Andreu D, Ley V, Sobrino F (2001) Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol 75:3164–3174
7. Brown F, Benkirane N, Limal D, Halimi H, Newman JFE, Van Regenmortel MHV, Briand JP, Muller S (1999) Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Vaccine 18:50–56
8. Cedillo-Barron L, Foster-Cuevas M, Belsham GJ, Lefevre F, Parkhouse RME (2001) Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82:1713–1724
9. Chan EWC, Wong HT, Cheng SCS, Yan WY, Zheng ZX, Sheng ZT, Zhu LQ, Xie Y (2001) An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine. Vaccine 19:538–546
10. Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ (1998) Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 72:4454–4457
11. Collen T (1994) Foot-and-mouth disease (aphthovirus): viral T cell epitopes. In: Goddeevis BML, Morrison WI (eds) Cell mediated immunity in ruminants. CRC Press, Inc., Boca Raton, Fla, pp 173–197
12. Collen T, DiMarchi R, Doel TR (1991) A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146:749–755
13. pol) as an immunodominant T-cell immunogen. Virus Res 56:125–133
14. Crowther JR, Farias S, Carpenter WC, Samuel AR (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74:1547–1553
15. Cubillos C, de la Torre BG, Jakab A, Clementi G, Borras E, Barcena J, Andren D, Sobrino F, Blanco E (2008) Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol 82:7223–7230
16. DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
17. Doel TR (2003) FMD vaccines. Virus Res 91:81–99
18. Foster M, Cook A, Cedillo L, Parkhouse RME (1998) Serological and cellular immune responses to non-structural proteins in animals infected with FMDV. Vet Q 20:28–30
19. Francis MJ, Hastings GZ, Syred AD, Mcginn B, Brown F, Rowlands DJ (1987) Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T cell determinants. Nature 330:168–170
20. Garcia-Briones MM, Blanco E, Chiva C, Andreu D, Ley V, Sobrino F (2004) Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology 322:264–275
21. Gerner W, Denyer MS, Takamatsu HH, Wileman TE, Wiesmuller KH, Pfaff E, Saalmuller A (2006) Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine. Virus Res 121:223–228
22. Golde WT, Pacheco JM, Duque H, Doel T, Penfold B, Ferman GS, Gregg DR, Rodriguez LL (2005) Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23:5775–5782
23. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17:465–493
24. Hamblin C, Barnett ITR, Hedger RS (1986) A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods 93:115–121
25. Jimenez-Clavero MA, Escribano-Romero E, Sanchez-Vizcaino JM, Ley V (1998) Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus. Virus Res 57:163–170
26. Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM (2006) DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J Gene Med 8:1182–1191
27. Kitching RP, Knowles NJ, Samuel AR, Donaldson AI (1989) Development of foot-and-mouth disease virus strain characterisation—a review. Trop Anim Health Prod 21:153–166
28. Kitson JDA, McCahon D, Belsham GJ (1990) Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
29. Knowles NJ, Samuel AR (2003) Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91:65–80
30. Li Z, Yi Y, Yin X, Zhang Z, Liu J (2008) Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS ONE 3:e2273. doi:10.1371/journal.pone.0002273
31. Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, Sette A (2002) A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol 168:5499–5506
32. Lofthouse SA, Kajihara M, Nagahara S, Nash A, Barcham GJ, Sedgmen B, Brandon MR, Sano A (2002) Injectable silicone implants as vaccine delivery vehicles. Vaccine 20:1725–1732
33. Mason PW, Piccone ME, McKenna TSC, Chinsangaram J, Grubman MJ (1997) Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96–102
34. McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm U (1992) Protective immune response against foot-and-mouth disease. J Virol 66:1835–1840
35. Morgan DO, Moore DM (1990) Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am J Vet Res 51:40–45
36. Mulcahy G, Gale C, Robertson P, Iyisan S, DiMarchi RD, Doel TR (1990) lsotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8:249–256
37. Mulcahy G, Reid E, DiMarchi RD, Gale C, Doel TR (1992) Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus. Res Vet Sci 52:133–140
38. Oldstone MBA, Lewicki H, Borrow P, Hudrisier D, Gairin JE (1995) Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol 69:7423–7429
39. Perry BD, Rich KM (2007) Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control. Vet Rec 160:238–241
40. Pfaff E, Mussgay M, Bohm HO, Schulz GE, Schaller H (1982) Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J 1:869–874
41. Qian P, Li XM, Jin ML, Peng GQ, Chen HC (2004) An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 22:2129–2136
42. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497
43. Rodriguez LL, Gay CG (2011) Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev Vaccine 10:377–387
44. Rodriguez LL, Grubman MJ (2009) Foot and mouth disease virus vaccines. Vaccine 27:D90–D94
45. Rodriguez LL, Barrera J, Kramer E, Lubroth J, Brown F, Golde WT (2003) A synthetic peptide containing the consensus sequence of the G–H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21:3751–3756
46. Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32:1–30
47. Taboga O, Tami C, Carrillo E, Nunez JI, Rodriguez A (1997) A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 71:2606–2614
48. Terpstra C, Frenkel S, Straver PJ, Barteling SJ, van Bekkum JG (1976) Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines. Vet Micro 1:333–342
49. Udenfriend S, Stein S, Bohlen P, Dairman W, Leimgruber W, Weigele M (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins and primary amines in the Pico mol range. Science 178:871–872
50. Valero ML, Camarero JA, Adeva A, Verdaguer N, Fita I, Mateu MG, Domingo E, Giralt E, Andreu D (1995) Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus. Biomed Pept Protein Nucl Acids 1:133–140
51. Volpina OM, Surovoy AY, Zhmak MN, Kuprianova MA, Koroev DO, Chepurkin AV, Toloknov AS, Ivanov VT (1999) A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Vaccine 17:577–584
52. Wang CY, Chang TY, Walfield AM, Ye J, Shen M, Chen SP, Li MC, Lin YL, Jong MH, Yang PC, Chyr N, Kramer E, Brown F (2002) Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603–2610
53. Wigdorovitz A, Carrillo C, Santos MJD, Trono K, Peralta A, Gomez MC, Rios RD, Franzone PM, Sadir AM, Escribano JM, Borca MV (1999) Induction of a protective antibody response to foot-and-mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255:347–353
54. Yang M, Clavijo A, Li MY, Hole K, Holland H, Wang H, Deng MY (2007) Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications. J Immunol Methods 321:174–181
55. Zamorano P, Wigdorovitz A, Perez-Filgueira M, Carrillo C, Escribano JM, Sadir AM, Borca MV (1995) A 10-amino-acid linear sequence of VP1 of foot-and-mouth disease virus containing B- and T- cell epitopes induces protection in mice. Virology 212:614–621
56. Zhang Q, Yang YQ, Zhang ZY, Li I, Yan WY, Jiang WJ, Xin AG, Lei CX, Zheng ZX (2002) Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia1 for guinea pigs. Acta Virol 46:1–9